Manufacturer record
Ravian Life Sciences Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Ravian Life Sciences Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between November 2019 and April 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
5 records linked to Ravian Life Sciences Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ramipril Tablets IP 2.5 mg | BPRA25002Mfg 2025-04 · Exp 2027-03 | Test for Dissolution and Assay for RamiprilAssay | DTL, Bengaluru, KarnatakaState lab | Apr 2026 |
| Nebivolol Tablets IP | KMNB 24002Mfg 2024-10 · Exp 2026-09 | It fails the test for ?Dissolution? as per IP, as Specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab | Apr 2025 |
| Nebivolol Tablets IP | KMNB2400 1Mfg 2024-07 · Exp 2026-06 | The sample does not conform to IP standards. It fails the test ?Dissolution? Specified in the Laboratory Protocol as per IPDissolution | DTL ThiruvananthapuramState lab | Nov 2024 |
| Clopidogrel Tablets IP 75 mg | CPDT21002Mfg 2021-08 · Exp 2023-07 | AssayAssay | RDTL ChandigarhCDSCO lab | Nov 2022 |
| Ramipril Tablets I.P. 2.5 mg | RAPT18004Mfg 2018-12 · Exp 2020-11 | AssayAssay | CDL KolkataCDSCO lab | Nov 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.